Combination Treatment with Liposomal Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells.

Autor: Orel VE; National Cancer Institute, 33/43 Zdanovska Str., 03022 Kyiv, Ukraine.; National Technical University of Ukraine 'Igor Sikorsky Kyiv Polytechnic Institute', 16/2 Yangel Str., 03056 Kyiv, Ukraine., Diedkov AG; National Cancer Institute, 33/43 Zdanovska Str., 03022 Kyiv, Ukraine., Ostafiichuk VV; National Cancer Institute, 33/43 Zdanovska Str., 03022 Kyiv, Ukraine., Lykhova OO; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, 45 Vasylkivska Str., 03022 Kyiv, Ukraine., Kolesnyk DL; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, 45 Vasylkivska Str., 03022 Kyiv, Ukraine., Orel VB; National Cancer Institute, 33/43 Zdanovska Str., 03022 Kyiv, Ukraine.; National Technical University of Ukraine 'Igor Sikorsky Kyiv Polytechnic Institute', 16/2 Yangel Str., 03056 Kyiv, Ukraine., Dasyukevich OY; National Cancer Institute, 33/43 Zdanovska Str., 03022 Kyiv, Ukraine., Rykhalskyi OY; National Cancer Institute, 33/43 Zdanovska Str., 03022 Kyiv, Ukraine., Diedkov SA; National Cancer Institute, 33/43 Zdanovska Str., 03022 Kyiv, Ukraine., Prosvietova AB; National Technical University of Ukraine 'Igor Sikorsky Kyiv Polytechnic Institute', 16/2 Yangel Str., 03056 Kyiv, Ukraine.

Publikováno v: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Jan 19; Vol. 17 (1). Date of Electronic Publication: 2024 Jan 19.